US78349D1072
© Globe Newswire
22.12.2025
RXST
LISTED
NASDAQ
RxSight, Inc. Announces Chief Financial Officer Transition
News Preview
ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that Shelley Thunen, the Company’s Chief Financial Officer, is transitioning from her role. Ms. Thunen will remain with the Company...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.11.2025
RXST
LISTED
NASDAQ
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
News Preview
ALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – November 20, 2025 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Piper Sandler 37th Annual Healthcare Conference in New Yo...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
RXST
LISTED
NASDAQ
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) and reminds investors of the September 22, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi &...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
19.09.2025
RXST
LISTED
NASDAQ
Deadline Soon: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming September 22, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) securities between May 7, 2024 and July 8, 2025, inclusive (the “Class Per...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
17.09.2025
RXST
LISTED
NASDAQ
EXTENDED CLASS PERIOD: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against RxSight, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
News Preview
Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of RxSight, Inc. (NASDAQ: RXST) common stock between May 7, 2024 and July 8, 2025, inclusive (the “Class Period”). Captioned Gémesi v. RxSight, Inc., No. 25-cv-02093 (C.D. Cal.), the RxSight class action lawsuit charges RxSight a...
Themefolio
Profiler
Peergroup
© BusinessWire
12.09.2025
RXST
LISTED
NASDAQ
RXST Deadline: Rosen Law Firm Urges RxSight, Inc. (NASDAQ: RXST) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025. RxSight describes itself as a “commercial-stage medical technology company, engaged in the research and development, manufactur...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
RXST
LISTED
NASDAQ
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
RXST
LISTED
NASDAQ
RxSight, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RXST
News Preview
The DJS Law Group reminds investors of a class action lawsuit against RxSight, Inc. (“RxSight” or “the Company”) (NASDAQ: RXST) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of RXST during the class per...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.08.2025
RXST
LISTED
NASDAQ
RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference
News Preview
ALISO VIEJO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Morgan Stanley Healthcare Conference in New York City....
Themefolio
Profiler
Peergroup
© BusinessWire
28.07.2025
RXST
LISTED
NASDAQ
RXST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that the RxSight class action lawsuit – captioned Makaveev v. RxSight, Inc., No. 25-cv-01596 (C.D. Cal.) – seeks to represent purchasers or acquirers of RxSight, Inc. (NASDAQ: RXST) securities and charges RxSight as well as certain of RxSight’s executives with violations of the Securit...
Themefolio
Profiler
Peergroup
© BusinessWire
25.07.2025
RXST
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) and reminds investors of the September 22, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi &...
Themefolio
Profiler
Peergroup
© BusinessWire
25.07.2025
RXST
LISTED
NASDAQ
Deadline Approaching: RxSight, Inc. (RXST) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming September 22, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”).
IF YOU ARE AN INVESTOR...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
24.07.2025
RXST
LISTED
NASDAQ
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming September 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Peri...
Themefolio
Profiler
Peergroup
© BusinessWire
24.07.2025
RXST
LISTED
NASDAQ
RXST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that the RxSight class action lawsuit – captioned Makaveev v. RxSight, Inc., No. 25-cv-01596 (C.D. Cal.) – seeks to represent purchasers or acquirers of RxSight, Inc. (NASDAQ: RXST) securities and charges certain of RxSight’s executives with violations of the Securities Exchange Act of...
Themefolio
Profiler
Peergroup
© BusinessWire
23.07.2025
RXST
LISTED
NASDAQ
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RxSight, Inc. (“RxSight” or “the Company”) (NASDAQ: RXST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investor...
Themefolio
Profiler
Peergroup
© BusinessWire
23.07.2025
RXST
LISTED
NASDAQ
RXST LEGAL UPDATE: RxSight, Inc. Sued for Fraud Amid Declining LAL Utilization -- Investors with Losses are Notified to Contact BFA Law before September 22 Class Action Deadline
News Preview
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Company’s senior executives for potential violations of the federal securities laws.
If you invested in RxSight, you are encouraged to obtain additional information by visiting: https://www.bf...
Themefolio
Profiler
Peergroup
© BusinessWire
23.07.2025
RXST
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages RxSight, Inc. (RXST) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”). RxSight investors have until September 22, 2025 to file a lead plaintiff motion....
Themefolio
Profiler
Peergroup
© BusinessWire
23.07.2025
RXST
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages RxSight, Inc. (RXST) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”). RxSight investors have until September 22, 2025 to file a lead plaintiff motion.
I...
Themefolio
Profiler
Peergroup
© BusinessWire
23.07.2025
RXST
LISTED
NASDAQ
Rosen Law Firm Urges RxSight, Inc. (NASDAQ: RXST) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025. RxSight describes itself as a “commercial-stage medical technology company, engaged in the research and development, manufacture, and s...
Themefolio
Profiler
Peergroup
© BusinessWire
22.07.2025
RXST
LISTED
NASDAQ
RXST CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit On Behalf Of RxSight, Inc. Investors
News Preview
Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Central District of California, captioned Makaveev v. RxSight, Inc., et al., Case No. 8:25-cv-01596, on behalf of persons and entities that purchased or otherwise acquired RxSight, Inc. (“RxSight” or the “Company”...
Themefolio
Profiler
Peergroup
© BusinessWire
21.07.2025
RXST
LISTED
NASDAQ
RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – RXST
News Preview
The DJS Law Group announces that it is investigating claims on behalf of investors of RxSight, Inc. (“RxSight” or “the Company”) (NASDAQ: RXST) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. R...
Themefolio
Profiler
Peergroup
© BusinessWire
18.07.2025
RXST
LISTED
NASDAQ
RXST Investors Have Opportunity to Join RxSight, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of RxSight, Inc. (“RxSight” or “the Company”) (NASDAQ: RXST) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclo...
Themefolio
Profiler
Peergroup
© BusinessWire
17.07.2025
RXST
LISTED
NASDAQ
RXST BREAKING NEWS: BFA Law is Investigating RxSight, Inc. for Securities Fraud; Contact the Firm about how to Potentially Recover Investment Losses
News Preview
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into RxSight, Inc. (NASDAQ: RXST) for potential violations of the federal securities laws.
If you invested in RxSight, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/rxsight-inc-class-action-lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
16.07.2025
RXST
LISTED
NASDAQ
Securities Fraud Investigation Into RxSight, Inc. (RXST) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON RXSIGHT, INC. (RXST), CLICK HERE TO INQ...
Themefolio
Profiler
Peergroup
© BusinessWire
16.07.2025
RXST
LISTED
NASDAQ
RxSight, Inc. (RXST) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith continues its investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN RXSIGHT, INC. (RXST), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSU...
Themefolio
Profiler
Peergroup
© BusinessWire
15.07.2025
RXST
LISTED
NASDAQ
Securities Fraud Investigation Into RxSight, Inc. (RXST) Continues – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz continues its investigation of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON RXSIGHT, INC. (RXST), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVE...
Themefolio
Profiler
Peergroup
© BusinessWire
11.07.2025
RXST
LISTED
NASDAQ
Securities Fraud Investigation Into RxSight, Inc. (RXST) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON RXSIGHT, INC...
Themefolio
Profiler
Peergroup
© BusinessWire
11.07.2025
RXST
LISTED
NASDAQ
RxSight, Inc. (RXST) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN RXSIGHT, INC. (RXST), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUI...
Themefolio
Profiler
Peergroup
© BusinessWire
10.07.2025
RXST
LISTED
NASDAQ
Securities Fraud Investigation Into RxSight, Inc. (RXST) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON RXSIGHT, INC. (RXST), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.05.2025
RXST
LISTED
NASDAQ
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum
News Preview
ALISO VIEJO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Stifel Virtual Ophthalmology Forum....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.04.2025
RXST
LISTED
NASDAQ
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
News Preview
ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced select preliminary revenue results for the first quarter 2025 and revised full-year 2025 guidance. The Company wi...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.03.2025
RXST
LISTED
NASDAQ
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
News Preview
ALISO VIEJO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming 24th Annual Needham Virtual Healthcare Conference....
Themefolio
Profiler
Peergroup
© Globe Newswire
25.02.2025
RXST
LISTED
NASDAQ
RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance
News Preview
ALISO VIEJO, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced financial results for the three months and full-year ended December 31, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
RXST
LISTED
NASDAQ
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
News Preview
ALISO VIEJO, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the fourth quarter of 2024 after the market close on Tuesday, February 25, 2025. The comp...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2025
RXST
LISTED
NASDAQ
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
News Preview
ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth quarter and full-year 2024 and prov...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2025
RXST
LISTED
NASDAQ
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
News Preview
ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.08.2024
RXST
LISTED
NASDAQ
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
News Preview
ALISO VIEJO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced its plans to participate in two upcoming healthcare conferences in September....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.08.2024
RXST
LISTED
NASDAQ
RxSight, Inc. Reports Second Quarter 2024 Financial Results
News Preview
ALISO VIEJO, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended June 30, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.05.2024
RXST
LISTED
NASDAQ
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
News Preview
ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced today that it has priced its underwritten public offering. RxSight expects to sell 1,785,714 shares of its common stock...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
